PRESS RELEASE published on 07/23/2024 at 10:06, 1 year 8 months ago Original-Research: Ikonisys SA (von Sphene Capital GmbH): Buy Sphene Capital GmbH updates research report on Ikonisys SA, adjusting price target to EUR 5.50 from EUR 6.30. Company's 2023 financial figures below expectations, 2024 forecasts driven by collaborations Financial Figures Ikonisys SA Price Target Collaborations Sphene Capital GmbH
BRIEF published on 07/18/2024 at 19:10, 1 year 8 months ago Ikonisys Completes €250k Capital Increase Via Private Placement Private Placement Capital Increase Financial Resources Cancer Detection Ikonisys
BRIEF published on 07/18/2024 at 19:10, 1 year 8 months ago Ikonisys finalise une augmentation de capital de 250 000 € via un placement privé Placement Privé Augmentation De Capital Ressources Financières Détection Du Cancer Ikonisys
PRESS RELEASE published on 07/18/2024 at 19:05, 1 year 8 months ago Inside Information / Operations of the issuer (acquisitions, sales...) Ikonisys completed a €250k capital increase through a private placement with CC Holding Srl to strengthen financial resources for commercial development Private Placement Capital Increase Financial Resources Ikonisys Commercial Development
PRESS RELEASE published on 07/18/2024 at 19:05, 1 year 8 months ago Informations privilégiées / Opérations de l'émetteur (acquisitions, cessions...) Ikonisys finalise une augmentation de capital de 250 K€ via un placement privé avec CC Holding Srl pour renforcer ses ressources financières et son développement commercial Placement Privé Augmentation De Capital Développement Commercial Ikonisys CC Holding Srl
BRIEF published on 06/11/2024 at 18:35, 1 year 9 months ago Ikonisys and Ulisse Biomed enter into a strategic partnership for cancer diagnosis Innovation Biotechnology Partnership Diagnostic Cancer
BRIEF published on 06/11/2024 at 18:35, 1 year 9 months ago Ikonisys et Ulisse Biomed nouent un partenariat stratégique pour le diagnostic du cancer Innovation Biotechnologie Partenariat Diagnostic Cancer
PRESS RELEASE published on 06/11/2024 at 18:30, 1 year 9 months ago Inside Information / Other news releases Ikonisys and Ulisse Biomed announce strategic partnership to enhance cancer diagnostics through technical and commercial collaboration, aiming to provide innovative solutions and maximize market penetration Innovation Strategic Partnership Cancer Diagnostics Ikonisys Ulisse Biomed
PRESS RELEASE published on 06/11/2024 at 18:30, 1 year 9 months ago Informations privilégiées / Autres communiqués Ikonisys et Ulisse Biomed annoncent un partenariat stratégique pour soutenir l'innovation dans le domaine du diagnostic du cancer Innovation Partenariat Stratégique Ikonisys Diagnostic Du Cancer Ulisse Biomed
BRIEF published on 06/03/2024 at 21:04, 1 year 9 months ago Ikonisys finalise une augmentation de capital pour stimuler son expansion commerciale Placement Privé Augmentation De Capital Expansion Commerciale Ikonisys Intégration Hospitex
Published on 03/26/2026 at 04:55, 3 hours 51 minutes ago Vanta Announces Capital Markets Initiatives to Strengthen Financial Position and Support Growth Initiatives
Published on 03/26/2026 at 00:40, 8 hours 6 minutes ago Challenger RC Resource Upgrade Drilling Complete
Published on 03/26/2026 at 00:30, 8 hours 16 minutes ago Nano One Highlights Recent Objectives & Reports Fourth Quarter 2025 Results
Published on 03/25/2026 at 19:15, 13 hours 31 minutes ago Gemina Laboratories Ltd. Announces Delisting from the CSE
Published on 03/26/2026 at 08:20, 26 minutes ago Eurobattery Minerals initiates comprehensive metallurgical testwork with SLR for the San Juan tungsten project
Published on 03/26/2026 at 08:00, 45 minutes ago PNE AG closes the 2025 financial year with successful operational performance and focuses on core markets and profitability
Published on 03/26/2026 at 08:00, 46 minutes ago Appointment and Retirement of Non-Executive Directors
Published on 03/26/2026 at 08:00, 46 minutes ago CANCOM SE: CANCOM confirms preliminary figures; 2026 forecast published
Published on 03/26/2026 at 08:00, 46 minutes ago LPKF reports slight improvement in earnings in 2025 and initiates Group realignment
Published on 03/26/2026 at 07:30, 1 hour 16 minutes ago BIOPHYTIS-LYNXKITE ALLIANCE INVITED TO NVIDIA CONFERENCE: UNLEASHING AI TO REVOLUTIONIZE LONGEVITY
Published on 03/26/2026 at 07:30, 1 hour 16 minutes ago BIOPHYTIS ET LYNXKITE INVITÉS À LA CONFÉRENCE NVIDIA : L’IA AU SERVICE DE LA LONGÉVITÉ
Published on 03/25/2026 at 18:53, 13 hours 52 minutes ago CIS - Transfert Contrat de Liquidité Portzamparc - 25.03.2026
Published on 03/25/2026 at 18:31, 14 hours 15 minutes ago Strong investment performance and active roll-out of our strategy
